Clinical

Our Partnerships

partnerships-discovery

Broad Capabilities for Singular Results

WuXi NextCODE is the world’s most powerful genome analytics solution. It enables diagnostic marker identification and carrier searches at speeds and scale impossible on any other platform.

Every project is unique, and the breadth of our platform means we can provide all the capabilities you need to apply the genome to improve health, at unmatched speed and scale. Whether you keep your data in-house or in the cloud, only our data architecture enables you to: validate your diagnoses with your collaborators, find clinically-relevant disease variants in data gathered and stored at multiple sites, and run it against massive reference sets, all as though it was sitting on your desktop hard drive. Our analytics can be bundled with our range of sequencing, secondary processing and cloud storageto give you superlative results faster.

For more details and a customized proposal to meet your needs, get in touch and the right member of our team will get straight back to you.

Genomics England

Genomics England

Genomics England has selected WuXi NextCODE as the only Clinical Interpretation Partner working across the breadth of the 100,000 Genomes Project. WuXi NextCODE is the first to work with them on cancer samples and will also interpret samples in rare disease. Genomics England is working with WuXi NextCODE to drive up the quality of interpretation of genomic data. This will lead to better understanding of disease and more personalised care for patients in the future.

News Articles

Wuxi NextCODE Wins Genomics England...

More

Groundbreaking ‘San Antonio 1000 Cancer...

More

WuXi NextCODE to Interpret Cancer...

More

WuXi NextCODE Gets 100,000 Genomes...

More

WuXi NextCODE Lands Starring Role...

More
Fudan University

Fudan University

The partnership with Fudan-led Collaborative Innovation Center of Genetics and Development (CICGD) will empower CICGD scientists to perform gene sequencing and bioinformatics analysis with unparalleled speed and precision, thereby accelerating research, clinical diagnosis, and treatment of rare inherited diseases and malignant tumors.